Redline of Final Rule Revising the Confidentiality of Alcohol and Drug Abuse Patient Records Regulations

February 28, 2017 Alerts and Newsletters

Verrill Dana's Health Care Group previously published an alert regarding the publication, on January 18, 2017, of a final rule revising the Confidentiality of Alcohol and Drug Abuse Patient Records regulations, commonly known as "Part 2" (the "Final Rule"), for the first time in 29 years. We have created a redlined version comparing the longstanding version of Part 2 against the Final Rule.

The Final Rule was scheduled to take effect on February 17, 2017, but, on January 20, 2017, the incoming Administration issued a freeze on recently published, but not yet effective, regulations, including the Final Rule. The Final Rule will therefore not become effective until March 21, 2017, at the earliest. Under the regulatory freeze, federal agencies are currently reviewing any recently published, but not yet effective, regulations for questions of fact, law, and policy. If no questions exist, the regulations will be effective 60 days after the January 20th freeze was issued, on March 21st. If questions do exist, the agency at issue, SAMHSA in this case, may consider proposing for notice and comment a rule to delay the effective date beyond that 60-day period and may consider potentially proposing further notice-and-comment rulemaking.

Download a PDF of Verrill Dana's redline of the final rule revising the Confidentiality of Alcohol and Drug Abuse Patient Records regulations.

Firm Highlights


Nearly 80 Verrill Attorneys Recognized by Best Lawyers® 2021, Including a Dozen Named Lawyers of the Year

(August 24, 2020) – Nearly 80 Verrill attorneys were recognized as "Best Lawyers" by Best Lawyers® 2021 , including 12 attorneys named “Lawyer of the Year,” a distinguished recognition for only a single lawyer...


The Regulatory Sprint is Over - What’s at the Finish Line Under the New Stark and AKS Final Rules?

The U.S. Department of Health and Human Services (HHS) completed its “Regulatory Sprint” by finalizing changes to regulations pertaining to two federal fraud and abuse laws. On December 2, 2020, the Centers for Medicare...


340B Providers Get Partial Relief from New Dispute Resolution Regulation

1. 340B ADR Process Established At long last, more than ten years after Congress directed it to do so, HHS has finalized an alternative dispute resolution (“ADR”) process for both providers and pharmaceutical manufacturers...


HHS Confirms Providers’ Right to 340B Discount Pricing for Contract Pharmacies

As a holiday gift to providers, the U.S. Department of Health and Human Services (HHS) General Counsel recently issued a strongly worded Advisory Opinion indicating that federal law requires drug manufacturers to deliver covered...


Michael K. Fee to Lead Verrill’s Nationally-Recognized Health Care and Life Sciences Practice Amidst Recent Changes

(August 31, 2020) – Verrill is pleased to announce Michael K. Fee as the new leader of Verrill’s nationally-recognized Health Care & Life Sciences Group. The Group has a long history of representing a...


European Union GDPR—Institution

Counseled a preeminent health system and academic medical center on its compliance with the European Union General Data Protection Regulation (GDPR) in relation to its clinical and research activities, including its international research studies...


Multi-Site Global Research

Developed and negotiated site and coordinating center agreements in connection with a multi-site, international, National Institutes of Health (NIH)-funded study, and advised on regulatory issues related to the conduct of the study and subsequent...


Conflicts of Interest

Reviewed medical center's systems, policies and procedures for identifying, assessing, and managing investigator and institutional conflicts of interest.


Verrill Ranked in American Bar Association’s Health Law Top 10 in the Northeast

(January 19, 2021) – Verrill was recently ranked third in the American Bar Association (ABA) Health Law Section's Eighth Annual Top 10 Recognition for the Northeast Region. This is the sixth consecutive year that...


Massachusetts Health Care Bill Makes Several Significant Changes

While you were celebrating the New Year, Governor Baker signed Chapter 260 of the Acts of 2020, an “Act promoting a resilient health care system that puts patients first,” the result of the Legislature’s...

Contact Verrill at (855) 307 0700